Vaxess Technologies today announced a rebranding to Terrestrial Bio, Inc., along with $50 million in Series C financing.

In this interview, Dr. John Bishop discusses the scientific and regulatory challenges of NAM adoption, where companies should ...

Alongside the rebrand, Terrestrial is planning to establish a new headquarters and manufacturing facility in Boston.

Micron Biomedical, a clinical stage company developing dissolvable, needle-free products that could replace injectable pharmaceuticals and vaccines, today announced it was named to the number two spot ...

Genomics improves healthcare and prevention of all major diseases by early personalized insight into health, and Europe needs ...

A bargain DNA kit ordered on a whim seemed like harmless fun for one British woman, until the results unsettled her family's ...

Understanding gene expression within the body has been a boon for 21st century biology and therapeutics, but most discoveries ...

Botstein, Princeton’s Anthony B. Evnin ‘62 Professor of Genomics, Emeritus, and an emeritus professor of molecular biology ...

Two decades of cloning experiments in mice have produced a striking pattern: animals created through somatic cell nuclear ...

Understanding gene expression within the body has been a boon for 21st century biology and therapeutics, but most discoveries that use these ...

Understanding gene expression within the body has been a boon for 21st century biology and therapeutics, but most discoveries ...